Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview

Autoimmune hepatitis (AIH) is a unique form of immune-mediated disease that attacks the liver through a variety of immune mechanisms. The outcomes of AIH are either acute liver disease, which can be fatal, or, more commonly, chronic progressive liver disease, which can lead to decompensated liver ci...

Full description

Bibliographic Details
Main Authors: Hind I. Fallatah, Hisham O. Akbar
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:Autoimmune Diseases
Online Access:http://dx.doi.org/10.1155/2012/312817
id doaj-6edc6f529e3f4c1692eafe06e8873aa7
record_format Article
spelling doaj-6edc6f529e3f4c1692eafe06e8873aa72020-11-25T02:03:27ZengHindawi LimitedAutoimmune Diseases2090-04222090-04302012-01-01201210.1155/2012/312817312817Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical OverviewHind I. Fallatah0Hisham O. Akbar1Medical Department, Arab Board and Saudi Board of Internal Medicine, MACP, King Abdul Aziz University Hospital, P.O. Box 9714, Jeddah 21423, Saudi ArabiaKing Abdul Aziz University Hospital, Jeddah, Saudi ArabiaAutoimmune hepatitis (AIH) is a unique form of immune-mediated disease that attacks the liver through a variety of immune mechanisms. The outcomes of AIH are either acute liver disease, which can be fatal, or, more commonly, chronic progressive liver disease, which can lead to decompensated liver cirrhosis if left untreated. AIH has characteristic immunological, and pathological, features that are important for the establishment of the diagnosis. More importantly, most patients with AIH have a favorable response to treatment with prednisolone and azathioprine, although some patients with refractory AIH or more aggressive disease require more potent immune-suppressant agents, such as cyclosporine or Mycophenolate Mofetil. In this paper, we discuss the immunological, pathological and clinical features of AIH, as well as the standard and alternative treatments for AIH.http://dx.doi.org/10.1155/2012/312817
collection DOAJ
language English
format Article
sources DOAJ
author Hind I. Fallatah
Hisham O. Akbar
spellingShingle Hind I. Fallatah
Hisham O. Akbar
Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview
Autoimmune Diseases
author_facet Hind I. Fallatah
Hisham O. Akbar
author_sort Hind I. Fallatah
title Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview
title_short Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview
title_full Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview
title_fullStr Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview
title_full_unstemmed Autoimmune Hepatitis as a Unique Form of an Autoimmune Liver Disease: Immunological Aspects and Clinical Overview
title_sort autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview
publisher Hindawi Limited
series Autoimmune Diseases
issn 2090-0422
2090-0430
publishDate 2012-01-01
description Autoimmune hepatitis (AIH) is a unique form of immune-mediated disease that attacks the liver through a variety of immune mechanisms. The outcomes of AIH are either acute liver disease, which can be fatal, or, more commonly, chronic progressive liver disease, which can lead to decompensated liver cirrhosis if left untreated. AIH has characteristic immunological, and pathological, features that are important for the establishment of the diagnosis. More importantly, most patients with AIH have a favorable response to treatment with prednisolone and azathioprine, although some patients with refractory AIH or more aggressive disease require more potent immune-suppressant agents, such as cyclosporine or Mycophenolate Mofetil. In this paper, we discuss the immunological, pathological and clinical features of AIH, as well as the standard and alternative treatments for AIH.
url http://dx.doi.org/10.1155/2012/312817
work_keys_str_mv AT hindifallatah autoimmunehepatitisasauniqueformofanautoimmuneliverdiseaseimmunologicalaspectsandclinicaloverview
AT hishamoakbar autoimmunehepatitisasauniqueformofanautoimmuneliverdiseaseimmunologicalaspectsandclinicaloverview
_version_ 1724948135155859456